Related Experiment Video
Updated: Apr 8, 2026

Field Identification of Matricaria chamomilla using a Portable qPCR System
Published on: October 10, 2020
Development of Safe and Effective Botanical Dietary Supplements
1UIC/NIH Center for Botanical Dietary Supplements Research, Department of Medicinal Chemistry and Pharmacognosy, University of Illinois College of Pharmacy , 833 S. Wood Street, Chicago, Illinois 60612, United States.
Botanical dietary supplements require enhanced safety and efficacy measures. Pharmaceutical-like development, including clinical studies, is crucial for safe and effective botanical products.
Area of Science:
- Pharmacology
- Natural Products Chemistry
- Regulatory Science
Background:
- The global market for botanical dietary supplements is expanding.
- Current U.S. FDA regulations mandate good manufacturing practices (GMP) for safety, but efficacy is not required.
- Botanical supplements are regulated differently than drugs or foods.
Purpose of the Study:
- To propose a comprehensive development framework for botanical dietary supplements.
- To enhance the safety and efficacy of botanical products.
- To align botanical supplement development with pharmaceutical standards.
Main Methods:
- Identification of mechanisms of action and active constituents.
- Chemical and biological standardization based on active compounds and pharmacological activity.
- Preclinical evaluation including toxicity and drug-botanical interactions.
- Metabolism studies of active compounds.
- Clinical trials for safety and efficacy.
Main Results:
- A proposed pharmaceutical-like development pathway for botanical supplements.
- Emphasis on scientific rigor from identification to clinical validation.
- Framework addresses safety, efficacy, and regulatory considerations.
Conclusions:
- Implementing a pharmaceutical-style development process will ensure safer and more effective botanical dietary supplements.
- This approach facilitates the translation of botanicals from raw materials to reliable human use.
- Additional safeguards beyond GMP are necessary for robust product development.
More Related Videos
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
06:47Measuring Volatile and Non-volatile Antifungal Activity of Biocontrol Products
Published on: December 5, 2020
Related Concept Videos
Preclinical Development: Overview
Drug Regulation
Clinically Relevant Drug Product Specifications: Methods of Establishment
Clinical Trials: Overview
FDA Approved Drugs: Changes to Approved Drugs
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules